Investigating if E4orf1 can stop Alzheimer's disease from getting worse in older mice
Official title: Does E4orf1 prevent further deterioration in Alzheimer's disease pathology in older mice
Funded at Texas Tech University · NIH-10491189 · Data updated 2026-11-12
This study is looking at a protein called E4orf1 to see if it can help stop Alzheimer's disease from getting worse in older mice, and it hopes to find new ways to treat the disease by understanding how Alzheimer's and Type 2 Diabetes are connected.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Tech University NIH-funded |
| Lab location | 1 site (Lubbock, United States) |
| Project start | September 30, 2021 |
| Project end | June 30, 2025 |
| Funding year | 2022 |
| Award (this year) | $224,407 |
| NIH project number | 5R21AG068940-02 |
| Project ID | NIH-10491189 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults experiencing early signs of Alzheimer's disease or those at risk due to related conditions like Type 2 Diabetes.
✕Less likely to help
Patients with advanced Alzheimer's disease or those without any cognitive decline may not benefit from this research.
What this research studies
This research explores the potential of E4orf1, a protein, to prevent the worsening of Alzheimer's disease in older mice. By examining the relationship between Alzheimer's and Type 2 Diabetes, the study aims to uncover shared mechanisms that could lead to effective treatment strategies. The approach involves analyzing how E4orf1 interacts with molecular pathways involved in Alzheimer's progression. If successful, this research could pave the way for new therapies that might slow down or halt the disease's advancement.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow the progression of Alzheimer's disease.
How similar studies have gone: Previous research has shown promise in using anti-diabetic medications to improve cognitive function, indicating potential for success in this area.
Where this research is happening
-
Texas Tech University
Lubbock, United States Active
Researchers
- Principal investigator: Hegde, Vijay Karkal — Texas Tech University
- Study coordinator: Hegde, Vijay Karkal
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.